Overview

A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if the combination of gemcitabine and oxaliplatin is effective for triple negative breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborator:
Sanofi
Treatments:
Gemcitabine
Oxaliplatin